MEIS1 and colorectal carcinoma: Notably, three MBE motifs were discovered in the promoter region of human miR-23a (Figure S3), and miR-23a is highly expressed in patients with colorectal cancer (CRC), whereas MEIS1 is lowly expressed [35,36].